Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Pramipexole

Research Leaders

5 sponsors active, led by National Institute of Mental Health (NIMH)

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed1
Active Not Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Pramipexole1
  • Artwork Present1
  • Artwork Absent1
  • Social Connection High1
  • Social Connection Low1

Active Sponsors

  • National Institute of Mental Health (NIMH)2
  • Yale University1
  • New York State Psychiatric Institute1
  • University of California, Davis1
  • University of California, San Diego1

Top Investigators

Related Conditions

  • Anxiety Disorders1
  • Depression1
  • Anxiety1
  • Chronic Pain1

Activity Timeline